StonvexLoading…
StonvexCore line items from LKQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.65B | $13.82B | $13.27B | $12.79B |
Operating Income | $993.00M | $1.15B | $1.32B | $1.58B |
Net Income | $608.00M | $693.00M | $938.00M | $1.15B |
EPS (Diluted) | $2.35 | $2.62 | $3.49 | $4.13 |
Total Assets | $15.14B | $14.96B | $15.08B | $12.04B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $319.00M | $234.00M | $299.00M | $278.00M |
Free Cash Flow OCF − CapEx | $847.00M | $810.00M | $998.00M | $1.03B |
Shares Outstanding | 255.00M | 259.10M | 267.20M | 267.30M |